Wednesday Sep 16, 2026
Wednesday Sep 16, 2026
Friday, 4 September 2026 00:13 - - {{hitsCtrl.values.hits}}
The 12th International Exhibition on Pharma and Healthcare, IPHEX 2026 from 7–9 September at Bharat Mandapam, New Delhi, will bring over 900 Indian exhibitors and upwards of 50,000 visitors to New Delhi this September, cementing its place as India’s flagship platform for the pharmaceutical and healthcare
industry.
Organised by PHARMEXCIL under the Department of Commerce, the exhibition covers the full spectrum of the sector — Active Pharmaceutical Ingredients (APIs), finished formulations, bulk drugs, drug intermediates, excipients, contract manufacturing, biosimilars, vaccines, nutraceuticals, surgical care, animal health, and clinical research
organisations.
India already supplies a large share of Sri Lanka’s pharmaceutical imports, and healthcare cooperation remains a recurring priority in bilateral trade discussions between Colombo and New Delhi. IPHEX offers a single venue to meet a concentrated pool of Indian manufacturers and exporters, rather than pursuing scattered individual outreach.
For importers and distributors, direct engagement with API and formulation manufacturers can mean sharper pricing and stronger quality assurance through first-hand relationships. For Sri Lanka’s own manufacturers exploring contract production and export markets, the event connects them with technology providers, potential joint-venture partners, and CROs that could support local research and development. Public and private healthcare institutions sourcing vaccines, surgical consumables, and nutraceuticals also stand to benefit from direct supplier access.
IPHEX runs a Hosted Buyer Program for overseas delegates, with eligible participants qualifying for economy airfare reimbursement and complimentary hotel accommodation as per policy — a meaningful incentive that lowers the cost of attending. Separate registration tracks exist for pharma associations and chambers of commerce, and for Government procurement agencies, making the event equally relevant to individual companies and to Sri Lankan industry bodies looking to engage collectively. Trade journalists can also register to cover developments shaping the region’s healthcare supply chains.
As Sri Lanka balances the need for affordable, reliable medicine access with ambitions to build export-oriented pharmaceutical manufacturing, IPHEX offers a direct line into where the region’s healthcare industry is heading. Given the scale of the event, early registration is advisable to secure meaningful B2B meeting slots. Sri Lankan pharmaceutical companies, distributors, healthcare institutions, and industry associations can register through the Hosted Buyer, Association, or Procurement Agency links on the official IPHEX
website.
